
Epizyme, Inc., a company at the forefront of research and development in the field of cancer therapies that work against epigenetic targets, recently announced a breakthrough in their research, which will pave the way for therapies that will be able to safely and effectively treat certain types of human lymphomas. The research that led to [...]